Ophthalmologists should consider treating glaucoma earlier and more aggressively than called for in current guidelines, according to Iqbal Ike K. Ahmed, MD.
"It's a time for change, partly because the current treatment paradigm is not working well," said Dr. Ahmed, medical director, Prism Eye Institute; associate professor of ophthalmology, University of Toronto, and clinical professor of ophthalmology, University of Utah.
The advent of microinvasive glaucoma surgery (MIGS) has opened up new opportunities to control primary open-angle glaucoma with earlier intervention, he said.
Dr. Ahmed made his case for "interventional glaucoma" in the Drs. Henry and Frederick Sutro Memorial Lecture at the 7th annual Glaucoma 360 New Horizons Forum, hosted by the Glaucoma Research Foundation.
In addition to making use of MIGS, interventional glaucoma might utilize other novel drainage devices and sustained drug-delivery devices and be combined with cataract surgery, he said. This approach is more proactive, aims at lower IOP, lowers risk and addresses adherence, he said.